FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention describes cyclic-substituted diphenylazethidinones of the formula (I): wherein each radical among R1, R2, R3, R4, R5 and R6 means independently of one another (C1-C30)-alkylene-(LAG)n wherein n = 1-2; one or two carbon atoms in alkylene residue are replaced with phenyl or piperazinyl residues or (C3-C10)-cycloalkyl residue; one or some carbon atoms in alkylene residue can be replaced with -S(O)n wherein n = 2; -O-, -(C=O)- or -NH-; hydrogen atom (H), fluorine atom (F), chlorine atom (Cl), bromine atom (Br), iodine atom (J), O-(C1-C6)-alkyl; (LAG)n means mono- or tricyclic trialkyl ammoniumalkyl residue, -(CH2)0-SO3H, -(CH2)0-COOH, -(CH2)0-C(=NH)(NH2), and pharmaceutically acceptable salts also. Proposed compounds decrease the serum cholesterol content. Also, invention describes using these compounds for preparing a medicinal agent used in treatment of lipid metabolism disorders.
EFFECT: valuable medicinal properties of compounds and pharmaceutical composition.
7 cl, 1 tbl, 22 ex
Title | Year | Author | Number |
---|---|---|---|
DIPHENYLAZETHIDINONES SUBSTITUTED WITH ACIDIC GROUPS, METHOD FOR THEIR PREPARING, MEDICINAL AGENT COMPRISING THEREOF AND THEIR USING | 2003 |
|
RU2287522C2 |
NOVEL 1,2-DIPHENYLAZEAZETHIDINONES, THEIR USING IN TREATMENT OF LIPID METABOLISM DISORDER, MEDICINAL AGENT AND METHOD FOR ITS PREPARING | 2001 |
|
RU2286985C2 |
CATION-SUBSTITUTED DIPHENYLAZETHIDINONES, METHOD FOR THEIR PREPARING, MEDICINAL AGENTS COMPRISING THESE COMPOUNDS AND THEIR USING | 2003 |
|
RU2315753C2 |
DERIVATIVES OF DIPHENYLAZETHIDINONE, MEDICINAL AGENTS COMPRISING THESE COMPOUNDS AND THEIR USING | 2001 |
|
RU2275370C2 |
DERIVATIVES OF DIPHENYLAZETHIDINONE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR ITS PREPARING | 2001 |
|
RU2282628C2 |
GLYCINE DERIVATIVES AND THEIR USE AS MUSCARINIC RECEPTOR ANTAGONISTS | 2011 |
|
RU2585767C2 |
METHOD OF PRODUCING 1,4-DIPHENYLAZETIDINONE DERIVATIVES | 2005 |
|
RU2380361C2 |
HETEROCYCLIC ARYL SULPHONES, SUITABLE FOR TREATING DISORDERS RESPONSIVE TO 5HT RECEPTOR MODULATION | 2007 |
|
RU2451012C2 |
ALKALOID ESTER AND CARBAMATE DERIVATIVES AND MEDICINAL COMPOSITIONS THEREOF | 2012 |
|
RU2611627C2 |
ALKALOID DERIVATIVES OF AMINOESTERS AND THEREOF-INCLUDING DRUG COMPOSITIONS | 2011 |
|
RU2569846C2 |
Authors
Dates
2008-01-27—Published
2003-06-04—Filed